Why BioNTech Stock Bumped Higher Today
A victory on the regulatory front and a bullish analyst move were the twin news items propelling BioNTech's (NASDAQ: BNTX) shares higher as the stock trading week began on Monday. The Germany-based biotech's equity rose by almost 3% in value during the session, comparing well to the 0.4% improvement of the S 500 index.
Friday afternoon, a vaccine advisory panel of the Centers for Disease Control and Prevention (CDC) narrowly voted against recommending a doctor's prescription to obtain shots of Covid vaccines in this country. BioNTech came to prominence during the Covid era as the co-developer (with ) of the go-to jab Comirnaty. To a degree, its reputation still rests on the product.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Stock
€22.60
0.470%
We see a rather positive sentiment for Pfizer Inc. with 15 Buy predictions and 2 Sell predictions.
As a result the target price of 27 € shows a slightly positive potential of 19.47% compared to the current price of 22.6 € for Pfizer Inc..
